76,99 €
This book summarizes the latest developments in key areas of the fast moving field of abdominal organ transplantation. It covers such vital topics as living donation (both renal and liver), laparoscopic and robotic techniques, islet and pancreas transplantation, non-heart beating transplantation, blood group incompatible and highly sensitized transplantation, high risk transplants, tolerance, stem cell therapy and novel immunosuppressive techniques. Each chapter offers an overview of the available evidence by a world renowned expert, written in an accessible, easy-to-read manner.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 426
Veröffentlichungsjahr: 2013
Table of Contents
Title Page
Copyright
List of Contributors
Foreword
Chapter 1: Living Donation: The Gold Standard
Introduction
Epidemiology
Advantages of living-kidney donation
Types of donor
Evaluation process for the live donor
Short-term and long-term risks of kidney donation
Conclusion
Chapter 2: New Surgical Techniques in Transplantation
Introduction
Live-donor nephrectomy: surgical techniques
Surgical advances in renal-transplantation techniques
Conclusion
Chapter 3: Living-donor Liver Transplantation
History
Donor evaluation
Recipient evaluation
Pediatric recipients
Adult-to-adult LDLT
Donor outcome
Recipient outcome
Conclusion
Chapter 4: Antibody-incompatible Transplantation
Introduction
Blood-group-incompatible transplantation
Principles of ABOi transplantation
HLA-incompatible transplantation
New developments in antibody-incompatible transplantation
Conclusion: what should we do with an antibody-incompatible recipient?
Chapter 5: Pancreas Transplantation
Introduction
Diabetes mellitus
Diabetes management
Pancreas transplantation: a routine technique?
Indications and contraindications for pancreas transplantation
Renal replacement therapy in diabetics
Expansion of the donor pool
Expansion of the recipient pool
Recipient pretransplant work-up
Choice of operation: SPK/PAK/PTA
Surgical aspects of pancreas transplantation
Postoperative management
Immunosuppression
Outcomes
The future
Chapter 6: Allotransplantation of Pancreatic Islets
Introduction
Rationale for islet transplantation
Historical background of islet transplantation
Donor selection and pancreas allocation
Pancreas retrieval and preservation
Islet isolation procedure
Islet recipient selection
Islet transplantation procedure
Post-transplant management
Immunosuppression
Summary of clinical outcomes
Ongoing challenges in islet transplantation
Chapter 7: Novel Cell Therapies in Transplantation
Introduction
Defined stem-cell populations for clinical application
Multipotent stromal cells
MSCs and solid-organ transplantation
How MSCs might work
Considerations for solid-organ transplantation
Pathfinder cells: an alternative to solid-organ pancreas transplantation?
Induced pluripotent stem cells
Neo-organogenesis for transplantation
Natural blueprints for stem cell–organ development: using fetal cells to grow an organ
The future
Chapter 8: Intestinal Transplantation
Introduction
Classification
Intestinal failure
Recipient selection
Deceased-donor graft procurement
Deceased-donor recipient operation
Living donors
Post-transplant care
Immunosuppression and rejection
Patient and graft outcome
Cost and quality of life
Summary and future directions
Chapter 9: Pediatric Renal Transplantation
Introduction
Pediatric ESRF
Pretransplantation work-up
Living-donor renal transplantation
Deceased-donor renal transplantation
Peritransplantation issues
Post-transplantation care
The future of pediatric transplantation
Chapter 10: Immunosuppressive Pharmacotherapy
Introduction
Immunosuppressive therapies
Treatment of acute rejection
Future immunosuppressive agents
Chapter 11: Conclusion
Index
This edition first published 2013, © 2013 by Blackwell Publishing Ltd.
Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell's publishing program has been merged with Wiley's global Scientific, Technical and Medical business to form Wiley-Blackwell.
Registered office: John Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial offices: 9600 Garsington Road, Oxford, OX4 2DQ, UK
The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
111 River Street, Hoboken, NJ 07030-5774, USA
For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell.
The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services.
Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with the respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. It is sold on the understanding that the publisher is not engaged in rendering professional services and neither the publisher nor the author shall be liable for damages arising herefrom. If professional advice or other expert assistance is required, the services of a competent professional should be sought.
Library of Congress Cataloging-in-Publication Data
Abdominal organ transplantation : state of the art / edited by Nizam Mamode,
Raja Kandaswamy.
p. ; cm.
Includes bibliographical references and index.
ISBN 978-1-4443-3432-6 (cloth)
I. Mamode, Nizam. II. Kandaswamy, Raja.
[DNLM: 1. Abdomen– surgery. 2. Organ Transplantation– methods. WI 900]
617.5′5059– dc23
2012026232
A catalogue record for this book is available from the British Library.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books.
Cover design by : Nathan Harris
1 2013
This miscellaneous collection of articles on new developments in organ transplantation will be of very considerable interest to organ transplant clinicians. The chapters range from living donation of the kidney and liver to intestinal and pancreas the kidney, with a very good chapter on new surgical techniques in transplantation. In addition there is a comprehensive chapter on ABO incompatible renal transplantation and transplantation in the patient that is highly sensitized to HLA. There is a short review of the current status of pancreatic islet transplantation as well as an extensive review of new developments in pancreas transplantation. Furthermore paediatric renal transplantation is well covered and there are interesting contributions on novel cell therapies in transplantation as well as on immunosuppressive therapies, concentrating on more recent developments in this area. The final chapter by the two editors reviews the status of renal, liver, pancreas and intestinal transplantation, but in particular outlines the problems that still have to be resolved. The editors recognise that the current one year graft survival rates are at a level that was not considered remotely possible even as little as 20 years ago but accept that the longer term outcomes are still disappointing despite the introduction of many new immunosuppressive strategies. But in general they are very optimistic about the future.
Overall this book will be considered a very good read by the transplant clinician.
Sir Peter J Morris AC, FRS Director, Centre for Evidence in Transplantation, Royal College of Surgeons of England and London School of Hygiene and Tropical Medicine. Emeritus Nuffield Professor of Surgery, University of Oxford. Past President, Royal college of Surgeons. Honorary Professor, University of London.
Leonardo V. Riella and Anil Chandraker
Renal Division, Brigham and Women's Hospital, Harvard Medical School, USA
The first successful transplant occurred in Boston in 1954, when a surgical team under the direction of Joseph Murray removed a kidney from a healthy donor and transplanted it into his identical twin, who had chronic glomerulonephritis [1]. The organ functioned immediately and the recipient survived for 9 years, after which time his allograft failed from what was thought to be recurrent glomerulonephritis. More than 50 years have passed since that breakthrough achievement, and transplantation has progressed from an experimental modality to standard of care. The introduction of immunosuppressive drugs such as azathioprine, prednisone, and later calcineurin inhibitors has led to better outcomes and, along with technical breakthroughs, expanded the pool of organs available to deceased and human leukocyte antigen (HLA)-mismatched donors.
Kidney transplantation has become the preferred therapeutic option for patients with end-stage kidney disease (ESKD), leading to better patient survival and quality of life. It is also more cost-effective than dialysis [2–4]. Unfortunately, the incidence of ESKD has risen steadily in the past several decades, creating a shortage of available organs for patients on the kidney-transplant waiting list (Table 1.1).
Table 1.1 Waiting list for different organs in the USA. OPTN, Organ Procurement and Transplantation Network. Data from [5].
Waiting list candidates OPTN 2010
Number
All
107,075
Kidney
84,495
Pancreas
1,458
Kidney/Pancreas
2,182
Liver
15,948
Intestine
248
Heart
3,173
Lung
1,844
Heart/Lung
75
This growth in ESKD is related to the increased incidence of diabetes, obesity, and hypertension, combined with the improvement in treatment for concurrent health problems such as ischemic heart disease and stroke. The supply of organs from deceased donors has not followed the same upward trend, resulting in an ever-widening gap between eligible potential transplant recipients and available organs (Table 1.2).
Table 1.2 Growth of the kidney-transplant waiting list compared to donor type in the USA. Data from [5].
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
